Donor CD4 T cells trigger costimulation blockade-resistant donor bone marrow rejection through bystander activation requiring IL-6

American Journal of Transplantation

Volumn 14, Issue 9, 2014, Pages 2011-2022

  Hock, K ^a   Pilat, N ^a   Baranyi, U ^a   Mahr, B ^a   Gattringer, M ^a   Klaus, C ^a   Wekerle, T ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Basic (laboratory) research science; bone marrow hematopoietic stem cell transplantation; tolerance: chimerism; tolerance: costimulation blockade; tolerance: mechanisms; translational research science

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; LYMPHOTOXIN; RAPAMYCIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; BONE MARROW DISEASE; BONE MARROW REJECTION; BONE MARROW TRANSPLANTATION; BYSTANDER EFFECT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CELL PROLIFERATION; CELL TRANSFER; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GRAFT RECIPIENT; GRAFT REJECTION; IMMUNOSTIMULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; WHOLE BODY RADIATION; ANIMAL; FLOW CYTOMETRY; IMMUNOLOGY; INBRED MOUSE STRAIN;

ANIMALS; BONE MARROW TRANSPLANTATION; BYSTANDER EFFECT; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; FLOW CYTOMETRY; GRAFT REJECTION; INTERLEUKIN-6; MICE; MICE, INBRED STRAINS;

EID: 84906229666     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.12823     Document Type: Article

References (55)

1. Pilat N, Sayegh MH, Wekerle T., Costimulatory pathways in transplantation. Sem Immunol 2011; 23: 293-303.
2. Pilat N, Wekerle T., Transplantation tolerance through mixed chimerism. Nat Rev Nephrol 2010; 6: 594-605.
3. Pilat N, Hock K, Wekerle T., Mixed chimerism through donor bone marrow transplantation: A tolerogenic cell therapy for application in organ transplantation. Curr Opin Organ Transplant 2012; 17: 63-70.
4. Larsen CP, Page A, Linzie KH, et al. An MHC-defined primate model reveals significant rejection of bone marrow after mixed chimerism induction despite full MHC matching. Am J Transplant 2010; 10: 2396-2409.
5. Pilat N, Klaus C, Schwaiger E, Wekerle T., Hurdles to the induction of tolerogenic mixed chimerism. Transplantation 2009; 87 (9 Suppl): S79-S84.
6. Wekerle T, Kurtz J, Bigenzahn S, Takeuchi Y, Sykes M., Mechanisms of transplant tolerance induction using costimulatory blockade. Curr Opin Immunol 2002; 14: 592-600.
7. Kean LS, Hamby K, Koehn B, et al. NK cells mediate costimulation blockade-resistant rejection of allogeneic stem cells during nonmyeloablative transplantation. Am J Transplant 2006; 6: 292-304.
8. Kitchens WH, Haridas D, Wagener ME, et al. Integrin antagonists prevent costimulatory blockade-resistant transplant rejection by CD8(+) memory T cells. Am J Transplant 2012; 12: 69-80.
9. Ferrari-Lacraz S, Zheng XX, Kim YS, et al. An antagonist IL-15/Fc protein prevents costimulation blockade-resistant rejection. J Immunol 2001; 167: 3478-3485.
10. Zhao X, Boenisch O, Yeung M, et al. Critical role of proinflammatory cytokine IL-6 in allograft rejection and tolerance. Am J Transplant 2012; 12: 90-101.
11. Koporc Z, Pilat N, Nierlich P, et al. Murine mobilized peripheral blood stem cells have a lower capacity than bone marrow to induce mixed chimerism and tolerance. Am J Transplant 2008; 8: 2025-2036.
12. Ferrara JL, Deeg HJ., Graft-versus-host disease. N Engl J Med 1991; 324: 667-674.
13. Antin JH., T-cell depletion in GVHD: Less is more ? Blood 2011; 117: 6061-6062.
14. van den Brink MR, Burakoff SJ., Cytolytic pathways in haematopoietic stem-cell transplantation. Nat Rev Immunol 2002; 2: 273-281.
15. Martin PJ., The role of donor lymphoid cells in allogeneic marrow engraftment. Bone Marrow Transplant 1990; 6: 283-289.
16. Chakraverty R, Cote D, Buchli J, et al. An inflammatory checkpoint regulates recruitment of graft-versus-host reactive T cells to peripheral tissues. J Exp Med 2006; 203: 2021-2031.
17. Herndler-Brandstetter D, Landgraf K, Tzankov A, et al. The impact of aging on memory T cell phenotype and function in the human bone marrow. J Leukoc Biol 2012; 91: 197-205.
18. Mapara MY, Kim YM, Marx J, Sykes M., Donor lymphocyte infusion-mediated graft-versus-leukemia effects in mixed chimeras established with a nonmyeloablative conditioning regimen: Extinction of graft-versus-leukemia effects after conversion to full donor chimerism. Transplantation 2003; 76: 297-305.
19. Booth AJ, Grabauskiene S, Wood SC, Lu G, Burrell BE, Bishop DK., IL-6 promotes cardiac graft rejection mediated by CD4+ cells. J Immunol 2011; 187: 5764-5771.
20. Ferrer IR, Liu D, Pinelli DF, Koehn BH, Stempora LL, Ford ML., CD40/CD154 blockade inhibits dendritic cell expression of inflammatory cytokines but not costimulatory molecules. J Immunol 2012; 189: 4387-4395.
21. Coley SM, Ford ML, Hanna SC, Wagener ME, Kirk AD, Larsen CP., IFN-gamma dictates allograft fate via opposing effects on the graft and on recipient CD8 T cell responses. J Immunol 2009; 182: 225-233.
22. Rampersad RR, Tarrant TK, Vallanat CT, et al. Enhanced Th17-cell responses render CCR2-deficient mice more susceptible for autoimmune arthritis. PLoS ONE 2011; 6: e25833.
23. Ramsey H, Pilat N, Hock K, et al. Anti-LFA-1 or rapamycin overcome costimulation blockade-resistant rejection in sensitized bone marrow recipients. Transpl Int 2013; 26: 206-218.
24. Habicht A, Dada S, Jurewicz M, et al. A link between PDL1 and T regulatory cells in fetomaternal tolerance. J Immunol 2007; 179: 5211-5219.
25. Shen H, Goldstein DR,. IL-6 and TNF-alpha synergistically inhibit allograft acceptance. J Am Soc Nephrol 2009; 20: 1032-1040.
26. McCulloch MW, Bevan JA, Su C., Effects of phenoxybenzamine and norepinephrine on transmitter release in the pulmonary artery of the rabbit. Blood Vessels 1975; 12: 122-123.
27. Blazar BR, Taylor PA, Panoskaltsis-Mortari A, Gray GS, Vallera DA., Coblockade of the LFA1: ICAM and CD28/CTL A4: B7 pathways is a highly effective means of preventing acute lethal graft-versus-host disease induced by fully major histocompatibility complex-disparate donor grafts. Blood 1995; 85: 2607-2618.
28. Battaglia M, Stabilini A, Roncarolo MG., Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells. Blood 2005; 105: 4743-4748.
29. Reisman NM, Floyd TL, Wagener ME, Kirk AD, Larsen CP, Ford ML., LFA-1 blockade induces effector and regulatory T-cell enrichment in lymph nodes and synergizes with CTLA-4Ig to inhibit effector function. Blood 2011; 118: 5851-5861.
30. Hanidziar D, Koulmanda M., Inflammation and the balance of Treg and Th17 cells in transplant rejection and tolerance. Curr Opin Organ Transplant 2010; 15: 411-415.
31. Larsen CP, Elwood ET, Alexander DZ, et al. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 1996; 381: 434-438.
32. Blazar BR, Taylor PA, Sehgal SN, Vallera DA., Rapamycin, a potent inhibitor of T-cell function, prevents graft rejection in murine recipients of allogeneic T-cell-depleted donor marrow. Blood 1994; 83: 600-609.
33. Thomson AW, Turnquist HR, Raimondi G., Immunoregulatory functions of mTOR inhibition. Nat Rev Immunol 2009; 9: 324-337.
34. Corbascio M, Ekstrand H, Osterholm C, et al. CTLA4Ig combined with anti-LFA-1 prolongs cardiac allograft survival indefinitely. Transpl Immunol 2002; 10: 55-61.
35. Koporc Z, Bigenzahn S, Blaha P, et al. Induction of mixed chimerism through transplantation of CD45-congenic mobilized peripheral blood stem cells after nonmyeloablative irradiation. Biol Blood Marrow Transplant 2006; 12: 284-292.
36. Dazzi F, Szydlo RM, Craddock C, et al. Comparison of single-dose and escalating-dose regimens of donor lymphocyte infusion for relapse after allografting for chronic myeloid leukemia. Blood 2000; 95: 67-71.
37. Pelot MR, Pearson DA, Swenson K, et al. Lymphohematopoietic graft-vs.-host reactions can be induced without graft-vs.-host disease in murine mixed chimeras established with a cyclophosphamide-based nonmyeloablative conditioning regimen. Biol Blood Marrow Transplant 1999; 5: 133-143.
38. Kim YM, Mapara MY, Down JD, et al. Graft-versus-host-reactive donor CD4 cells can induce T cell-mediated rejection of the donor marrow in mixed allogeneic chimeras prepared with nonmyeloablative conditioning. Blood 2004; 103: 732-739.
39. Wekerle T, Kurtz J, Sayegh M, et al. Peripheral deletion after bone marrow transplantation with costimulatory blockade has features of both activation-induced cell death and passive cell death. J Immunol 2001; 166: 2311-2316.
40. Tough DF, Sprent J., Bystander stimulation of T cells in vivo by cytokines. Vet Immunol Immunopathol 1998; 63: 123-129.
41. Geginat J, Sallusto F, Lanzavecchia A., Cytokine-driven proliferation and differentiation of human naive, central memory, and effector memory CD4(+) T cells. J Exp Med 2001; 194: 1711-1719.
42. Tough DF, Borrow P, Sprent J., Induction of bystander T cell proliferation by viruses and type I interferon in vivo. Science 1996; 272: 1947-1950.
43. Unutmaz D, Pileri P, Abrignani S., Antigen-independent activation of naive and memory resting T cells by a cytokine combination. J Exp Med 1994; 180: 1159-1164.
44. Boyman O., Bystander activation of CD4+ T cells. Eur J Immunol 2010; 40: 936-939.
45. Weaver CT, Harrington LE, Mangan PR, Gavrieli M, Murphy KM., Th17: An effector CD4 T cell lineage with regulatory T cell ties. Immunity 2006; 24: 677-688.
46. Bettelli E, Carrier Y, Gao W, et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006; 441: 235-238.
47. Korn T, Bettelli E, Oukka M, Kuchroo VK., IL-17 and Th17 cells. Annu Rev Immunol 2009; 27: 485-517.
48. Chadha R, Heidt S, Jones ND, Wood KJ., Th17: Contributors to allograft rejection and a barrier to the induction of transplantation tolerance ? Transplantation 2011; 91: 939-945.
49. Bigenzahn S, Blaha P, Koporc Z, et al. The role of non-deletional tolerance mechanisms in a murine model of mixed chimerism with costimulation blockade. Am J Transplant 2005; 5: 1237-1247.
50. Wood KJ, Sakaguchi S., Regulatory T cells in transplantation tolerance. Nat Rev Immunol 2003; 3: 199-210.
51. Tawara I, Koyama M, Liu C, et al. Interleukin-6 modulates graft-versus-host responses after experimental allogeneic bone marrow transplantation. Clin Cancer Res 2011; 17: 77-88.
52. Chen X, Das R, Komorowski R, et al. Blockade of interleukin-6 signaling augments regulatory T-cell reconstitution and attenuates the severity of graft-versus-host disease. Blood 2009; 114: 891-900.
53. Hill GR, Ferrara JL., The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: Rationale for the use of cytokine shields in allogeneic bone marrow transplantation. Blood 2000; 95: 2754-2759.
54. Neujahr DC, Chen C, Huang X, et al. Accelerated memory cell homeostasis during T cell depletion and approaches to overcome it. J Immunol 2006; 176: 4632-4639.
55. Trambley J, Bingaman AW, Lin A, et al. Asialo GM1(+) CD8(+) T cells play a critical role in costimulation blockade-resistant allograft rejection. J Clin Invest 1999; 104: 1715-1722.